Arteris (AIP) Expected to Post Quarterly Earnings on Thursday

Arteris (NASDAQ:AIP) is projected to post its Q2 2026 results after the market closes on Thursday, August 6th. Analysts expect the company to announce earnings of ($0.05) per share and revenue of $23.4820 million for the quarter. Parties can find conference call details on the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Thursday, August 6, 2026 at 4:30 PM ET.

Arteris (NASDAQ:AIP) last issued its quarterly earnings data on Tuesday, May 12th. The company reported ($0.03) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.05. The firm had revenue of $22.94 million for the quarter, compared to the consensus estimate of $21.03 million. On average, analysts expect Arteris to post $-1 EPS for the current fiscal year and $-0 EPS for the next fiscal year.

Arteris Price Performance

Shares of AIP opened at $32.09 on Wednesday. Arteris has a 12-month low of $8.42 and a 12-month high of $50.26. The business has a 50-day simple moving average of $36.29 and a two-hundred day simple moving average of $25.97. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.17. The stock has a market cap of $1.48 billion, a PE ratio of -40.62 and a beta of 1.96.

Insider Buying and Selling

In other Arteris news, CFO Nicholas B. Hawkins sold 221,035 shares of the company’s stock in a transaction dated Friday, May 15th. The stock was sold at an average price of $33.40, for a total value of $7,382,569.00. Following the sale, the chief financial officer owned 110,600 shares in the company, valued at approximately $3,694,040. The trade was a 66.65% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, major shareholder Bayview Legacy, Llc sold 192,686 shares of the stock in a transaction dated Thursday, July 2nd. The shares were sold at an average price of $36.32, for a total value of $6,998,355.52. Following the completion of the sale, the insider directly owned 8,555,047 shares of the company’s stock, valued at approximately $310,719,307.04. The trade was a 2.20% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 1,364,949 shares of company stock valued at $48,244,576 over the last 90 days. 23.30% of the stock is owned by corporate insiders.

Institutional Trading of Arteris

Several institutional investors have recently added to or reduced their stakes in AIP. Intech Investment Management LLC increased its position in Arteris by 9.3% during the 4th quarter. Intech Investment Management LLC now owns 13,540 shares of the company’s stock valued at $210,000 after purchasing an additional 1,148 shares during the period. Deutsche Bank AG lifted its position in shares of Arteris by 7.7% in the 4th quarter. Deutsche Bank AG now owns 21,159 shares of the company’s stock worth $328,000 after purchasing an additional 1,504 shares during the period. BNP Paribas Financial Markets boosted its stake in shares of Arteris by 75.0% in the 3rd quarter. BNP Paribas Financial Markets now owns 6,053 shares of the company’s stock valued at $61,000 after purchasing an additional 2,595 shares during the last quarter. Public Employees Retirement System of Ohio boosted its stake in shares of Arteris by 12.3% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 23,913 shares of the company’s stock valued at $242,000 after purchasing an additional 2,613 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its position in shares of Arteris by 20.4% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 17,453 shares of the company’s stock worth $271,000 after buying an additional 2,955 shares during the period. 64.36% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Northland Securities set a $38.00 price target on Arteris in a research note on Wednesday, May 13th. Wall Street Zen downgraded Arteris from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Roth Capital began coverage on shares of Arteris in a report on Tuesday. They issued a “buy” rating and a $40.00 price objective for the company. Weiss Ratings downgraded shares of Arteris from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 13th. Finally, Jefferies Financial Group boosted their target price on shares of Arteris from $16.00 to $35.00 and gave the stock a “hold” rating in a report on Wednesday, May 13th. Four equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $38.50.

Arteris Company Profile

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.